In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Jolanda van der Velden
Jolanda van der Velden
Jolanda van der Velden Jolanda van der Velden

VU University Medical Center, Amsterdam (Netherlands (The))

Speciality : Myocardial Disease

Jolanda van der Velden, PhD, is chair of the Department for Physiology at the Amsterdam University Medical Center, and director of the Amsterdam Cardiovascular Sciences Institute. Since 2012 van der Velden is professor of the Netherlands Heart Institute. The main research interest of the van der Velden group is to study the role of sarcomere proteins in cardiac performance for which specific protein analyses and functional assays have been designed. As mutations in sarcomere proteins are a frequent cause of heart disease at young age, research on this topic was initiated with funding from European and prestigious national grants. The national research consotium (DOSIS) funded by the Netherlands Heart Foundation aims to study effects of genetic and environmental modifiers in cardiomyopathy. Studies on the genetic heart disease include basic cell and tissue analyses, which are combined with in vivo cardiovascular imaging in mouse models and human patients.

7 presentations from this speaker

All about myofilaments!

Event : Heart Failure 2019

  • Session : Hypertrophic cardiomyopathies: from gene to disease
  • Speaker : J van der Velden (Amsterdam,NL)

Sex-differences in cardiomyopathies: should we care?

Event : ESC Congress 2019

  • Session : Cardiomyopathies: translating innovations
  • Speaker : J van der Velden (Amsterdam,NL)

Genetic advances in cardiomyopathies

Event : ESC Congress 2016

  • Session : Taking heart failure genetics to the clinic
  • Speaker : J van der Velden (Amsterdam,NL)

Myofilament dysregulation.

Event : ESC Congress 2016

  • Session : Heart failure with preserved ejection fraction
  • Speaker : J van der Velden (Amsterdam,NL)

Sarcomeric dysfunction in the failing human heart

Event : Frontiers in CardioVascular Biology 2016

  • Session : Heart failure: from protein to phenotype
  • Speaker : J van der Velden (Amsterdam,NL)

Small molecule targeting of sarcomeric proteins.

Event : ESC Congress 2014

  • Session : Frontiers in the treatment of heart failure
  • Speaker : J van der Velden (Amsterdam,NL)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are